Investigating genetic vulnerabilities to radiation therapy

Raising the bar on radiation oncology excellence

How do disparities affect cancer patients across Europe?

What is the AMORIS study?

Results of 5 year phase III randomised trial treating localised prostate cancer

ECC 2015: Editor's highlights

ecancermedicalscience editor's choice for September 2015

Review of data and expert opinion from IMW 2015: Asian perspective

Surgery in synchronous oligometastatic disease

Diagnosis while pregnant should not lead to treatment delay or pregnancy termination

DDFMISO trial confirms significant negative prognostic value of tumour hypoxia

Results of a placebo­ controlled study of tasquinimod in men with metastatic castrate resistant prostate cancer